Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis
Clinical trial NCT01424670 · COMPLETED
Trial details
- NCT number
- NCT01424670
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-02
- Primary completion
- 2016-07-04
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.